Feedback from roadshow with CEO
We hosted a roadshow with the CEO, CFO and IR of Medartis and returned confident on the execution of the strategy laid out at the IPO. The key topic discussed with investors was the US, lagging slightly behind the initial plan as of H1 2018 results. However, the sales team build-up is progressing nicely but most importantly the development of IBRA in the country and modifications to some products to fit country specific surgeons’ needs, set to drive adoption, is well on track. CHF73 FV reiterated.
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.